383 — Tian An Medicare Income Statement
0.000.00%
Last trade - 00:00
- HK$738.48m
- HK$678.08m
- HK$1.57bn
2019 June 30th | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,196 | 1,194 | 1,463 | 1,438 | 1,569 |
Cost of Revenue | |||||
Gross Profit | 246 | 221 | 267 | 266 | 286 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,159 | 1,241 | 1,516 | 1,496 | 1,486 |
Operating Profit | 36.4 | -46.6 | -52.2 | -58.2 | 83.2 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -13.6 | -96.6 | -110 | -117 | 35.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 36.6 | -105 | -127 | -119 | 20.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 34.9 | -112 | -137 | -124 | 11.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 34.9 | -112 | -137 | -124 | 11.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.052 | -0.131 | -0.097 | -0.142 | 0.012 |
Dividends per Share |